LEGGETT THOMAS (Chief Financial Officer) sold 31.0% of their position (4.58K shares) of STOKE THERAPEUTICS, INC. on the open market
Open‑market sale worth $147.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 3/19/2026ACC: 0001774690-26-000006
Officer· Chief Financial Officer
Since Feb 2026
-4.58K
Net shares
Net seller
$147.1K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
4.58K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−1.27K
Price / share
$32.74
Trade value
$41.71K
% of position
8.6%
3/17/2026
14.75K→13.48K
Common Stock
Direct
Shares
−922.00
Price / share
$33.38
Trade value
$30.77K
% of position
6.8%
3/17/2026
13.48K→12.55K
Common Stock
Direct
Shares
−2.17K
Price / share
$31.28
Trade value
$67.98K
% of position
17.3%
3/18/2026
12.55K→10.38K
Common Stock
Direct
Shares
−172.00
Price / share
$31.79
Trade value
$5.47K
% of position
1.7%
3/18/2026
10.38K→10.21K
Common Stock
Direct
Shares
−37.00
Price / share
$32.85
Trade value
$1.22K
% of position
0.4%
3/18/2026
10.21K→10.17K
Total
Net shares
−4.58K
Net value
-$147.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −1.27K | $32.74 | $41.71K | 8.6% | 14.75K | 13.48K |
| Common Stock Direct | 3/17/2026 | S · Sale | −922.00 | $33.38 | $30.77K | 6.8% | 13.48K | 12.55K |
| Common Stock Direct | 3/18/2026 | S · Sale | −2.17K | $31.28 | $67.98K | 17.3% | 12.55K | 10.38K |
| Common Stock Direct | 3/18/2026 | S · Sale | −172.00 | $31.79 | $5.47K | 1.7% | 10.38K | 10.21K |
| Common Stock Direct | 3/18/2026 | S · Sale | −37.00 | $32.85 | $1.22K | 0.4% | 10.21K | 10.17K |
| Total | −4.58K | -$147.14K | ||||||
Derivative Transactions0
No derivative transactions reported